84 related articles for article (PubMed ID: 12541243)
1. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations.
Morvan D; Demidem A; Papon J; Madelmont JC
Magn Reson Med; 2003 Feb; 49(2):241-8. PubMed ID: 12541243
[TBL] [Abstract][Full Text] [Related]
2. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC
Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170
[TBL] [Abstract][Full Text] [Related]
3. Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study.
Morvan D; Demidem A; Madelmont JC
Pathol Biol (Paris); 2003 Jul; 51(5):256-9. PubMed ID: 14567189
[TBL] [Abstract][Full Text] [Related]
4. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
Guénin S; Morvan D; Thivat E; Stepien G; Demidem A
Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924
[TBL] [Abstract][Full Text] [Related]
5. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
[TBL] [Abstract][Full Text] [Related]
6. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
7. A model of phospholipid biosynthesis in tumor in response to an anticancer agent in vivo.
Behzadi M; Demidem A; Morvan D; Schwartz L; Stepien G; Steyaert JM
J Integr Bioinform; 2010 Mar; 7(3):. PubMed ID: 20375456
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
9. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?
Merle P; Morvan D; Caillaud D; Demidem A
Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820
[TBL] [Abstract][Full Text] [Related]
11. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
Dykes DJ; Griswold DP; Schabel FM
Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
[TBL] [Abstract][Full Text] [Related]
12. Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy.
Andronesi OC; Mintzopoulos D; Struppe J; Black PM; Tzika AA
J Magn Reson; 2008 Aug; 193(2):251-8. PubMed ID: 18556227
[TBL] [Abstract][Full Text] [Related]
13. Methionine-dependence phenotype of tumors: metabolite profiling in a melanoma model using L-[methyl-13C]methionine and high-resolution magic angle spinning 1H-13C nuclear magnetic resonance spectroscopy.
Morvan D; Demidem A; Guenin S; Madelmont JC
Magn Reson Med; 2006 May; 55(5):984-96. PubMed ID: 16598721
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
[TBL] [Abstract][Full Text] [Related]
15. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo].
Shkarin PIu; Sokolova IS; Gorbacheva LB; Sibel'dina LA
Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671
[No Abstract] [Full Text] [Related]
16. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
[TBL] [Abstract][Full Text] [Related]
17. Effect of pyridoxal 5'-phosphate and valproic acid on phospholipid synthesis in neuroblastoma NA.
Roberti R; Bocchini V; Freysz L; Vecchini A; Corazzi L; Arienti G; Porcellati F; Binaglia L
Biochem Pharmacol; 1989 Oct; 38(20):3407-13. PubMed ID: 2510734
[TBL] [Abstract][Full Text] [Related]
18. L-methionine supplementation accelerates tumour growth and shifts the phospholipid derivative pattern in a murine model of malignant melanoma. A proton HRMAS NMR spectroscopy study.
Demidem A; Morvan D; Papon J; Madelmont JC
IARC Sci Publ; 2002; 156():423-5. PubMed ID: 12484228
[No Abstract] [Full Text] [Related]
19. Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells.
Triba MN; Starzec A; Bouchemal N; Guenin E; Perret GY; Le Moyec L
NMR Biomed; 2010 Nov; 23(9):1009-16. PubMed ID: 20963798
[TBL] [Abstract][Full Text] [Related]
20. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
Cheng LL; Chang IW; Louis DN; Gonzalez RG
Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
